We are pleased to announce the appointment of Jonathan Milner, Ph.D., as the new non-executive chairman of the board, effective immediately. Dr. Milner is a distinguished entrepreneur and an influential figure in the UK life sciences and #biotech industry with a strong track record of fostering innovation. In addition to serving on several boards, he has contributed his expertise to numerous startups and established organisations, and we are grateful to have him at Healx. This transition comes as current chairman and co-founder David Brown, Ph.D., begins a secondment to pursue academic research at Trinity College, Cambridge University. Dr. Brown will remain an active member of the Healx board, continuing to contribute and support Tim Guilliams, Ph.D., co-founder and CEO of Healx, and Dr. Milner in advancing Healx’s mission. Read more about this update here:

We're extending our sincerest congratulations to Healx Co-founder David Brown, Ph.D., for being awarded the 2024 @OBN_UK Awards Special Recognition Award. Over the span of 50 years, and in addition to his leadership at Healx, he has worked with leading pharmaceutical companies and is responsible for many tremendous achievements, including the co-invention of Viagra during his time at Pfizer. His many accomplishments include improving access to medicines in less advantaged countries, sponsoring a global challenge to find innovative treatments for sepsis, and becoming an entrepreneur coach at Cambridge University Business School. We're grateful to work closely with Dr. Brown as he helps guide our mission of creating generative AI-powered, patient-inspired treatments for people living with #rarediseases.